1 recruiting, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Withdrawn 1 |
Follow ART: new trials by email Literature Review of ART trials Research Report on ART
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology Aspirin, Placebo - ART, Pre-Eclampsia | Phase 3 | Recruiting | University Hospital, Toulouse | 1164 | 2023-08-02 | 2026-05-07 |
| Doravirine and Weight Gain in Antiretroviral Naive DOR/3TC/TDF, DOR + FTC/TAF, BIC/FTC/TAF - Body Weight Changes, Human Immunodeficiency Virus | Phase 3 | Withdrawn | Prism Health North Texas | 2022-08-01 | 2023-05-12 |
Acquired Immunodeficiency Syndrome (1) · Body Weight Changes (1) · Fasting (1) · Metabolic Syndrome (1) · Obesity (1) · Pre-Eclampsia (1)
Urogenital Diseases (2) · Behavior (1) · Blood-Borne Infections (1) · Body Weight (1) · Communicable Diseases (1) · Feeding Behavior (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Glucose Metabolism Disorders (1) · HIV Infections (1) · Hyperinsulinism (1) · Hypertension, Pregnancy-Induced (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1)
Aspirin (1) · Receptors, Opioid, delta (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · doravirine (1) · emtricitabine tenofovir alafenamide (1)
Prism Health North Texas (1) · University Hospital, Toulouse (1)
France (1) · United States (1)
Roger Bedimo (1)